|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Fares J, Fares MY, Khachfe HH, Salhab HA
and Fares Y: Molecular principles of metastasis: A hallmark of
cancer revisited. Sig Transduct Target Ther. 5:282020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
4
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clayton NS and Ridley AJ: Targeting rho
GTPase signaling networks in cancer. Front Cell Dev Biol.
8:2222020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung H, Yoon SR, Lim J, Cho HJ and Lee HG:
Dysregulation of rho GTPases in human cancers. Cancers.
12:11792020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma N, Xu E, Luo Q and Song G: Rac1: A
regulator of cell migration and a potential target for cancer
therapy. Molecules. 28:29762023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crosas-Molist E, Samain R, Kohlhammer L,
Orgaz JL, George SL, Maiques O, Barcelo J and Sanz-Moreno V: Rho
GTPase signaling in cancer progression and dissemination. Physiol
Rev. 102:455–510. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Q, Zhuo Z, Qiu X, Luo R, Guo K, Wu H,
Jiang R, Li J, Lian Q, Chen P, et al: Adverse clinical outcomes and
immunosuppressive microenvironment of RHO-GTPase activation pattern
in hepatocellular carcinoma. J Transl Med. 22:1222024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caino MC and Altieri DC: Molecular
pathways: Mitochondrial reprogramming in tumor progression and
therapy. Clin Cancer Res. 22:540–545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Gregorio J, Petricca S, Iorio R,
Toniato E and Flati V: Mitochondrial and metabolic alterations in
cancer cells. Eur J Cell Biol. 101:1512252022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Markov N, Sabirova S, Sharapova G,
Gomzikova M, Brichkina A, Barlev NA, Egger M, Rizvanov A and Simon
HU: Mitochondrial, metabolic and bioenergetic adaptations drive
plasticity of colorectal cancer cells and shape their
chemosensitivity. Cell Death Dis. 16:2532025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
LeBleu VS, O'Connell JT, Gonzalez Herrera
KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A,
Domingos Chinen LT, Rocha RM, et al: PGC-1α mediates mitochondrial
biogenesis and oxidative phosphorylation in cancer cells to promote
metastasis. Nat Cell Biol. 16:992–1003. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
García-Heredia JM and Carnero A: Role of
mitochondria in cancer stem cell resistance. Cells. 9:16932020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boulton DP, Hughes CJ, Vaira V, Del Gobbo
A, Palleschi A, Locatelli M, Danis E, Raza M, Neumann AJ, Purdy SC,
et al: MIRO2 promotes cancer invasion and metastasis via MYO9B
suppression of RhoA activity. Cell Rep. 44:1151202025. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Junco M, Ventura C, Santiago Valtierra FX
and Maldonado EN: Facts, dogmas, and unknowns about mitochondrial
reactive oxygen species in cancer. Antioxidants. 13:15632024.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
An X, Yu W, Liu J, Tang D, Yang L and Chen
X: Oxidative cell death in cancer: Mechanisms and therapeutic
opportunities. Cell Death Dis. 15:5562024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Palma FR, Gantner BN, Sakiyama MJ, Kayzuka
C, Shukla S, Lacchini R, Cunniff B and Bonini MG: ROS production by
mitochondria: Function or dysfunction? Oncogene. 43:295–303. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Yang Z, Zhang S and Li J:
Miro-mediated mitochondrial transport: A new dimension for
disease-related abnormal cell metabolism? Biochem Biophys Res
Commun. 705:1497372024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boulton DP and Caino MC: Emerging roles
for Mitochondrial Rho GTPases in tumor biology. J Biol Chem.
300:1076702024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Y, An Y, Ren M, Wang H, Bai J, Du W
and Kong D: The mechanisms of action of mitochondrial targeting
agents in cancer: Inhibiting oxidative phosphorylation and inducing
apoptosis. Front Pharmacol. 14:12436132023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karp I and Lyakhovich A: Targeting cancer
stem cells with antibiotics inducing mitochondrial dysfunction as
an alternative anticancer therapy. Biochem Pharmacol.
198:1149662022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mathur S, Srivastava P, Srivastava A, Rai
NK, Abbas S, Kumar A, Tiwari M and Sharma LK: Regulation of
metastatic potential by drug repurposing and mitochondrial
targeting in colorectal cancer cells. BMC Cancer. 24:3232024.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Isazadeh H, Oruji F, Shabani S, Behroozi
J, Nasiri H, Isazadeh A and Akbari M: Advances in siRNA delivery
approaches in cancer therapy: Challenges and opportunities. Mol
Biol Rep. 50:9529–9543. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Johansson JM, Du Rietz H, Hedlund H,
Eriksson HC, Oude Blenke E, Pote A, Harun S, Nordenfelt P, Lindfors
L and Wittrup A: Cellular and biophysical barriers to lipid
nanoparticle mediated delivery of RNA to the cytosol. Nat Commun.
16:53542025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Corazao-Rozas P, Guerreschi P, André F,
Gabert PE, Lancel S, Dekiouk S, Fontaine D, Tardivel M, Savina A
and Quesnel B: Mitochondrial oxidative phosphorylation controls
cancer cell's life and death decisions upon exposure to MAPK
inhibitors. Oncotarget. 7:39473–39485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Porporato PE, Filigheddu N, Pedro JMBS,
Kroemer G and Galluzzi L: Mitochondrial metabolism and cancer. Cell
Res. 28:265–280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Faubert B, Solmonson A and DeBerardinis
RJ: Metabolic reprogramming and cancer progression. Science.
368:eaaw54732020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alshaabi H, Shannon N, Gravelle R,
Milczarek S, Messier T and Cunniff B: Miro1-mediated mitochondrial
positioning supports subcellular redox status. Redox Biology.
38:1018182021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brillo V, Chieregato L, Leanza L, Muccioli
S and Costa R: Mitochondrial dynamics, ROS, and cell signaling: A
blended overview. Life (Basel). 11:3322021.PubMed/NCBI
|
|
32
|
Capeloa T, Van De Velde JA, Pranzini E,
Ippolito L, Zampieri LX, Tardy M, Vazeille T, Provito A, Carrà G,
Scalera A, et al: Mitochondrial ROS inhibition prevents
doxorubicin-induced breast cancer cell migration and invasion.
iScience. 28:1130312025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim H, Sung JY, Park EK, Kho S, Koo KH,
Park SY, Goh SH, Jeon YK, Oh S, Park BK, et al: Regulation of
anoikis resistance by NADPH oxidase 4 and epidermal growth factor
receptor. Br J Cancer. 116:370–381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Szanto I: NADPH Oxidase 4 (NOX4) in
cancer: Linking redox signals to oncogenic metabolic adaptation.
Int J Mol Sci. 23:27022022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao J, Zhang J, Yu M, Xie Y, Huang Y,
Wolff DW, Abel PW and Tu Y: Mitochondrial dynamics regulates
migration and invasion of breast cancer cells. Oncogene.
32:4814–4824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Passaniti A, Kim MS, Polster BM and
Shapiro P: Targeting mitochondrial metabolism for metastatic cancer
therapy. Mol Carcinog. 61:827–838. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kumar A, Vaish M, Karuppagounder SS,
Gazaryan I, Cave JW, Starkov AA, Anderson ET, Zhang S, Pinto JT,
Rountree AM, et al: HIF1α stabilization in hypoxia is not
oxidant-initiated. Elife. 10:e728732021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Piskounova E, Agathocleous M, Murphy MM,
Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ
and Morrison SJ: Oxidative stress inhibits distant metastasis by
human melanoma cells. Nature. 527:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mollinedo F and Gajate C: Lipid rafts as
signaling hubs in cancer cell survival/death and invasion:
Implications in tumor progression and therapy: Thematic Review
Series: Biology of Lipid Rafts. J Lipid Res. 61:611–635. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pascual G, Avgustinova A, Mejetta S,
Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A,
Hueto JA, et al: Targeting metastasis-initiating cells through the
fatty acid receptor CD36. Nature. 541:41–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ghiglione N, Abbo D, Bushunova A,
Costamagna A, Porporato PE and Martini M: Metabolic plasticity in
pancreatic cancer: The mitochondrial connection. Mol Metab.
92:1020892025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Viale A, Pettazzoni P, Lyssiotis CA, Ying
H, Sánchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V,
et al: Oncogene ablation-resistant pancreatic cancer cells depend
on mitochondrial function. Nature. 514:628–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Senft D and Ronai ZA: Regulators of
mitochondrial dynamics in cancer. Curr Opin Cell Biol. 39:43–52.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Simoes ICM, Morciano G,
Lebiedzinska-Arciszewska M, Aguiari G, Pinton P, Potes Y and
Wieckowski MR: The mystery of mitochondria-ER contact sites in
physiology and pathology: A cancer perspective. Biochim Biophys
Acta Mol Basis Dis. 1866:1658342020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
DeBerardinis RJ and Chandel NS: We need to
talk about the Warburg effect. Nat Metab. 2:127–129. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lamb R, Ozsvari B, Lisanti CL, Tanowitz
HB, Howell A, Martinez-Outschoorn UE, Sotgia F and Lisanti MP:
Antibiotics that target mitochondria effectively eradicate cancer
stem cells, across multiple tumor types: Treating cancer like an
infectious disease. Oncotarget. 6:4569–4584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sciacovelli M and Frezza C:
Oncometabolites: Unconventional triggers of oncogenic signalling
cascades. Free Radic Biol Med. 100:175–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Andrzejewski S, Klimcakova E, Johnson RM,
Tabariès S, Annis MG, McGuirk S, Northey JJ, Chénard V, Sriram U,
Papadopoli DJ, et al: PGC-1α promotes breast cancer metastasis and
confers bioenergetic flexibility against metabolic drugs. Cell
Metab. 26:778–787.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
González A and Hall MN: Nutrient sensing
and TOR signaling in yeast and mammals. EMBO J. 36:397–408. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
DeNicola GM, Chen PH, Mullarky E, Sudderth
JA, Hu Z, Wu D, Tang H, Xie Y, Asara JM, Huffman KE, et al: NRF2
regulates serine biosynthesis in non-small cell lung cancer. Nat
Genet. 47:1475–1481. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Stine ZE, Walton ZE, Altman BJ, Hsieh AL
and Dang CV: MYC, metabolism, and cancer. Cancer Discov.
5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Molina JR, Sun Y, Protopopova M, Gera S,
Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, et
al: An inhibitor of oxidative phosphorylation exploits cancer
vulnerability. Nat Med. 24:1036–1046. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yap TA, Daver N, Mahendra M, Zhang J,
Kamiya-Matsuoka C, Meric-Bernstam F, Kantarjian HM, Ravandi F,
Collins ME, Francesco MED, et al: Complex I inhibitor of oxidative
phosphorylation in advanced solid tumors and acute myeloid
leukemia: Phase I trials. Nat Med. 29:115–126. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Boreel DF, Beerkens APM, Heskamp S,
Boswinkel M, Peters JPW, Adema GJ, Span PN and Bussink J:
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia
in murine tumor models. Clin Transl Radiat Oncol.
49:1008752024.PubMed/NCBI
|
|
56
|
Mukherjee S, Bhatti GK, Chhabra R, Reddy
PH and Bhatti JS: Targeting mitochondria as a potential therapeutic
strategy against chemoresistance in cancer. Biomed Pharmacother.
160:1143982023. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Škrtić M, Sriskanthadevan S, Jhas B,
Gebbia M, Wang X, Wang Z, Hurren R, Jitkova Y, Gronda M, Maclean N,
et al: Inhibition of mitochondrial translation as a therapeutic
strategy for human acute myeloid leukemia. Cancer Cell. 20:674–688.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Duivenvoorden WC, Popović SV, Lhoták S,
Seidlitz E, Hirte HW, Tozer RG and Singh G: Doxycycline decreases
tumor burden in a bone metastasis model of human breast cancer.
Cancer Res. 62:1588–1591. 2002.PubMed/NCBI
|
|
59
|
Nardo G, Pantziarka P and Conti M:
Synergistic potential of antibiotics with cancer treatments.
Cancers (Basel). 17:592024. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kashatus JA, Nascimento A, Myers LJ, Sher
A, Byrne FL, Hoehn KL, Counter CM and Kashatus DF: Erk2
Phosphorylation of Drp1 promotes mitochondrial fission and
MAPK-driven tumor growth. Mol Cell. 57:537–551. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ježek J, Cooper KF and Strich R: The
impact of mitochondrial Fission-stimulated ROS production on
Pro-apoptotic chemotherapy. Biology (Basel). 10:332021.PubMed/NCBI
|
|
62
|
Lei X, Lin H, Wang J, Ou Z, Ruan Y,
Sadagopan A, Chen W, Xie S, Chen B, Li Q, et al: Mitochondrial
fission induces immunoescape in solid tumors through decreasing
MHC-I surface expression. Nat Commun. 13:38822022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sharma A, Virmani T, Kumar G, Sharma A,
Virmani R, Gugulothu D, Singh K, Misra SK, Pathak K, Chitranshi N,
et al: Mitochondrial signaling pathways and their role in cancer
drug resistance. Cell Signal. 122:1113292024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kuntz EM, Baquero P, Michie AM, Dunn K,
Tardito S, Holyoake TL, Helgason GV and Gottlieb E: Targeting
mitochondrial oxidative phosphorylation eradicates
Therapy-resistant chronic myeloid leukemia stem cells. Nat Med.
23:1234–1240. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Milella M, Rutigliano M, Pandolfo SD,
Aveta A, Crocetto F, Ferro M, d'Amati A, Ditonno P, Lucarelli G and
Lasorsa F: The metabolic landscape of cancer stem cells: Insights
and implications for therapy. Cells. 14:7172025. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Suárez-Rivero JM, Pastor-Maldonado CJ,
Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I,
Talaverón-Rey M, Suárez-Carrillo A, Munuera-Cabeza M and
Sánchez-Alcázar JA: Mitochondria and antibiotics: For good or for
evil? Biomolecules. 11:10502021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Rodrigues T and Ferraz LS: Therapeutic
potential of targeting mitochondrial dynamics in cancer. Biochem
Pharmacol. 182:1142822020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Haga RB and Ridley AJ: Rho GTPases:
Regulation and roles in cancer cell biology. Small GTPases.
7:207–221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lawson CD and Ridley AJ: Rho GTPase
signaling complexes in cell migration and invasion. J Cell Biol.
217:447–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Humphries BA, Wang Z and Yang C: MicroRNA
regulation of the small rho GTPase Regulators-complexities and
opportunities in targeting cancer metastasis. Cancers (Basel).
12:10922020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mardilovich K, Olson MF and Baugh M:
Targeting Rho GTPase signaling for cancer therapy. Future Oncol.
8:165–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Cantelli G, Orgaz JL, Rodriguez-Hernandez
I, Karagiannis P, Maiques O, Matias-Guiu X, Nestle FO, Marti RM,
Karagiannis SN and Sanz-Moreno V: TGF-β-Induced transcription
sustains amoeboid melanoma migration and dissemination. Cur Biol.
25:2899–2914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
George S, Martin JAJ, Graziani V and
Sanz-Moreno V: Amoeboid migration in health and disease: Immune
responses versus cancer dissemination. Front Cell Dev Biol.
10:10918012023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen YQ, Huang CM, Liu CY, Chiou A, Wang
YK, Tang MJ and Kuo JC: β-PIX controls intracellular
viscoelasticity to regulate lung cancer cell migration. J Cell Mol
Med. 19:934–947. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Pittar A, Buckley EJ, Boyle ST, Ibbetson
SJ and Samuel MS: Enhanced RHO-ROCK signaling is associated with
CRELD2 production and fibroblast recruitment in cutaneous squamous
cell carcinoma. Cytoskeleton (Hoboken). 81:864–871. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Saliani M, Mirzaiebadizi A, Mosaddeghzadeh
N and Ahmadian MR: RHO GTPase-Related long noncoding RNAs in human
cancers. Cancers (Basel). 13:53862021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Brabletz S, Bajdak K, Meidhof S, Burk U,
Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J
and Brabletz T: The ZEB1/miR-200 feedback loop controls Notch
signalling in cancer cells. EMBO J. 30:770–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Slabáková E, Culig Z, Remšík J and Souček
K: Alternative mechanisms of miR-34a regulation in cancer. Cell
Death Dis. 8:e31002017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Augoff K, Das M, Bialkowska K, McCue B,
Plow EF and Sossey-Alaoui K: miR-31 is a broad regulator of
β1-Integrin expression and function in cancer cells. Mol Cancer
Res. 9:1500–1508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gan L, Zheng L, Zou J, Luo P, Chen T, Zou
J, Li W, Chen Q, Cheng L, Zhang F and Qian B: MicroRNA-21 in
urologic cancers: From molecular mechanisms to clinical
implications. Front Cell Dev Biol. 12:14379512024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Qian H, Maghsoudloo M, Kaboli PJ,
Babaeizad A, Cui Y, Fu J, Wang Q and Imani S: Decoding the promise
and challenges of miRNA-Based cancer therapies: An essential update
on miR-21, miR-34, and miR-155. Int J Med Sci. 21:2781–2798. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Xie N, Meng Q, Zhang Y, Luo Z, Xue F, Liu
S, Li Y and Huang Y: MicroRNA-142-3p suppresses cell proliferation,
invasion and epithelial-to-mesenchymal transition via RAC1-ERK1/2
signaling in colorectal cancer. Mol Med Rep. 24:5682021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Pahlavan Y, Mohammadi Nasr M, Dalir
Abdolahinia E, Pirdel Z, Razi Soofiyani S, Siahpoush S and Nejati
K: Prominent roles of microRNA-142 in cancer. Pathol Res Pract.
216:1532202020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hou X, Zaks T, Langer R and Dong Y: Lipid
nanoparticles for mRNA delivery. Nat Rev Mater. 6:1078–1094. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Jin Z, Al Amili M and Guo S: Tumor
Microenvironment-responsive drug delivery based on polymeric
micelles for precision cancer therapy: Strategies and prospects.
Biomedicines. 12:4172024. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zeng H, Zhang Y, Liu N, Wei Q, Yang F and
Li J: Stimulus-responsive nanodelivery and release systems for
cancer gene therapy: Efficacy improvement strategies. Int J
Nanomedicine. 19:7099–70121. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yaghmur A, Østergaard J and Mu H: Lipid
nanoparticles for targeted delivery of anticancer therapeutics:
Recent advances in development of siRNA and lipoprotein-mimicking
nanocarriers. Adv Drug Deliv Rev. 203:1151362023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kamerkar S, LeBleu VS, Sugimoto H, Yang S,
Ruivo CF, Melo SA, Lee JJ and Kalluri R: Exosomes facilitate
therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Nature. 546:498–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ubanako P, Mirza S, Ruff P and Penny C:
Exosome-mediated delivery of siRNA molecules in cancer therapy:
Triumphs and challenges. Front Mol Biosci. 11:14479532024.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Thomas RG, Surendran SP and Jeong YY:
Tumor Microenvironment-stimuli responsive nanoparticles for
anticancer therapy. Front Mol Biosci. 7:6105332020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Kazerounian S, Gerald D, Huang M, Chin YR,
Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L,
Pourat J, et al: RhoB differentially controls akt function in tumor
cells and stromal endothelial cells during breast tumorigenesis.
Cancer Res. 73:50–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Cummings JC, Zhang H and Jakymiw A:
Peptide carriers to the rescue: Overcoming the barriers to siRNA
delivery for cancer treatment. Transl Res. 214:92–104. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Altieri DC: Mitochondria on the move:
Emerging paradigms of organelle trafficking in tumour plasticity
and metastasis. Br J Cancer. 117:301–305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Denisenko TV, Gorbunova AS and Zhivotovsky
B: Mitochondrial involvement in migration, invasion and metastasis.
Front Cell Dev Biol. 7:3552019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Koundouros N and Poulogiannis G:
Phosphoinositide 3-Kinase/Akt signaling and redox metabolism in
cancer. Front Oncol. 8:1602018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yadav T, Gau D and Roy P:
Mitochondria-actin cytoskeleton crosstalk in cell migration. J Cell
Physiol. 237:2387–2403. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Nakao LS, Olson MF, Vázquez-Medina JP and
Valdivia A: Editorial: Reactive oxygen species (ROS) signaling
during cytoskeleton dynamics. Front Cell Dev Biol. 11:12952632023.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Rudzka DA, Cameron JM and Olson MF:
Reactive oxygen species and hydrogen peroxide generation in cell
migration. Commun Integr Biol. 8:e10743602015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Xu Q, Huff LP, Fujii M and Griendling KK:
Redox regulation of the actin cytoskeleton and its role in the
vascular system. Free Radic Biol Med. 109:84–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Muliyil S and Narasimha M: Mitochondrial
ROS regulates cytoskeletal and mitochondrial remodeling to tune
cell and tissue dynamics in a model for wound healing. Dev Cell.
28:239–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zheng XX, Chen JJ, Sun YB, Chen TQ, Wang J
and Yu SC: Mitochondria in cancer stem cells: Achilles heel or hard
armor. Trends Cell Biol. 33:708–727. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Fung TS, Chakrabarti R, Kollasser J,
Rottner K, Stradal TEB, Kage F and Higgs HN: Parallel kinase
pathways stimulate actin polymerization at depolarized
mitochondria. Curr Biol. 32:1577–1592.e8. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Fung TS, Chakrabarti R and Higgs HN: The
multiple links between actin and mitochondria. Nat Rev Mol Cell
Biol. 24:651–667. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Akter S, Madhuvilakku R, Kar AK, Nila IS,
Liu P, Inuzuka H, Wei W and Hong Y: Reactive oxygen species (ROS)
in cancer: From mechanism to therapeutic implications. Sig
Transduct Target Ther. 11:1112026. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Paulsen CE and Carroll KS:
Cysteine-mediated redox signaling: Chemistry, biology, and tools
for discovery. Chem Rev. 113:4633–4679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Schieber M and Chandel NS: ROS function in
redox signaling and oxidative stress. Curr Biol. 24:R453–R462.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Kelley LC, Chi Q, Cáceres R, Hastie E,
Schindler AJ, Jiang Y, Matus DQ, Plastino J and Sherwood DR:
Adaptive F-Actin polymerization and localized ATP production drive
basement membrane invasion in the absence of MMPs. Dev Cell.
48:313–328.e8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
López-Doménech G, Covill-Cooke C,
Ivankovic D, Halff EF, Sheehan DF, Norkett R, Birsa N and Kittler
JT: Miro proteins coordinate microtubule- and actin-dependent
mitochondrial transport and distribution. EMBO J. 37:321–336. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Qu C, Yang W, Kan Y, Zuo H, Wu M, Zhang Q,
Wang H, Wang D and Chen J: RhoA/ROCK Signaling regulates
Drp1-mediated mitochondrial fission during collective cell
migration. Front Cell Dev Biol. 10:8825812022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Cangkrama M, Liu H, Wu X, Yates J, Whipman
J, Gäbelein CG, Matsushita M, Ferrarese L, Sander S, Castro-Giner
F, et al: MIRO2-mediated mitochondrial transfer from cancer cells
induces cancer-associated fibroblast differentiation. Nat Cancer.
6:1714–1733. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Caino MC and Altieri DC: Cancer cells
exploit adaptive mitochondrial dynamics to increase tumor cell
invasion. Cell Cycle. 14:3242–3247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Liu H, Yin H, Wang Z, Yuan Q, Xu F, Chen Y
and Li C: Rho A/ROCK1 signaling-mediated metabolic reprogramming of
valvular interstitial cells toward Warburg effect accelerates
aortic valve calcification via AMPK/RUNX2 axis. Cell Death Dis.
14:1082023. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Alasadi A, Fadhil N and Chen S:
Deciphering the critical roles of the AMPK/mTOR signaling pathway
in cancer cell metabolism (review). World Acad Sci J. 7:1–18. 2025.
View Article : Google Scholar
|
|
117
|
Collins SE, Wiegand ME, Werner AN, Brown
IN, Mundo MI, Swango DJ, Mouneimne G and Charest PG: Ras-mediated
activation of mTORC2 promotes breast epithelial cell migration and
invasion. Mol Biol Cell. 34:ar92023. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Soriano O, Alcón-Pérez M,
Vicente-Manzanares M and Castellano E: The crossroads between RAS
and RHO signaling pathways in cellular transformation, motility and
contraction. Genes. 12:8192021. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Xu J, Hao S, Han K, Yang W and Deng H: How
is the AKT/mTOR pathway involved in cell migration and invasion?
Biocell. 47:773–788. 2023. View Article : Google Scholar
|
|
120
|
Cho HM, Ryu JR, Jo Y, Seo TW, Choi YN, Kim
JH, Chung JM, Cho B, Kang HC, Yu SW, et al: Drp1-Zip1 interaction
regulates mitochondrial quality surveillance system. Mol Cell.
73:364–376.e8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Modi S, López-Doménech G, Halff EF,
Covill-Cooke C, Ivankovic D, Melandri D, Arancibia-Cárcamo IL,
Burden JJ, Lowe AR and Kittler JT: Miro clusters regulate
ER-mitochondria contact sites and link cristae organization to the
mitochondrial transport machinery. Nat Commun. 10:43992019.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Ghosh S, Dash P, Das P and Nayak B: Ligand
Targeted Polymeric Nanoparticles for Cancer Chemotherapy. Padhi S,
Behera A and Lichtfouse E: Polymeric nanoparticles for the
treatment of solid tumors [Internet] Cham: Springer International
Publishing; 2022 pp. 251–272. Sep 27–2025, (Environmental Chemistry
for a Sustainable World). Available from:. https://link.springer.com/10.1007/978-3-031-14848-4_9doi:10.1007/978-3-031-14848-4_9.
View Article : Google Scholar
|
|
123
|
Indrajit R and Goutam G: Aberrant
signaling pathways in cancer cells: Application of nanomaterials. J
Cell Signal. 2:281–299. 2021.
|
|
124
|
Blazanin N, Liang X, Mahmud I, Kim E,
Martinez S, Tan L, Chan W, Anvar NE, Ha MJ, Qudratullah M, et al:
Therapeutic modulation of ROCK overcomes metabolic adaptation of
cancer cells to OXPHOS inhibition and drives synergistic anti-tumor
activity. bioRxiv. Sep 20–2024.doi: 10.1101/2024.09.16.613317.
|
|
125
|
Keoh LQ, Chiu CF and Ramasamy TS:
Metabolic plasticity and cancer stem cell metabolism: Exploring the
Glycolysis-OXPHOS switch as a mechanism for resistance and
tumorigenesis. Stem Cell Rev Rep. 21:2446–2468. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Witzigmann D, Kulkarni JA, Leung J, Chen
S, Cullis PR and Van Der Meel R: Lipid nanoparticle technology for
therapeutic gene regulation in the liver. Adv Drug Deliv Rev.
159:344–363. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Pan J, Rostamizadeh K, Filipczak N and
Torchilin VP: Polymeric Co-Delivery systems in cancer treatment: An
overview on component drugs' Dosage ratio effect. Molecules.
24:10352019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Tazawa H, Ishida Y, Suzuki T, Shimizu Y
and Tashiro H: Delivery of lipid nanoparticles containing small
interfering RNA targeting transmembrane serine protease 4 in a
human gastric cancer model using nude mice. Sci Rep. 15:450532025.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wang X and Gerdes HH: Transfer of
mitochondria via tunneling nanotubes rescues apoptotic PC12 cells.
Cell Death Differ. 22:1181–1191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Steeg PS: Targeting metastasis. Nat Rev
Cancer. 16:201–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Panchal K and Tiwari AK: Miro
(Mitochondrial Rho GTPase), a key player of mitochondrial axonal
transport and mitochondrial dynamics in neurodegenerative diseases.
Mitochondrion. 56:118–135. 2021. View Article : Google Scholar : PubMed/NCBI
|
